Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers

BACKGROUND: Dyslipidemia in metabolic syndrome may introduce an underestimation of the risk for cardiovascular disease (CVD) using Low-Density Lipoprotein-Cholesterol (LDL-C) as a surrogate marker. Recently, non-High-Density Lipoprotein-Cholesterol (non-HDL-C), Apolipoprotein B (ApoB) and remnant-Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergström, Helena, Ekström, Lena, Warnqvist, Anna, Bergman, Peter, Björkhem-Bergman, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058971/
https://www.ncbi.nlm.nih.gov/pubmed/33879161
http://dx.doi.org/10.1186/s12905-021-01306-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058971/
https://www.ncbi.nlm.nih.gov/pubmed/33879161
http://dx.doi.org/10.1186/s12905-021-01306-4

Ejemplares similares